Skip to main content
. Author manuscript; available in PMC: 2022 Dec 15.
Published in final edited form as: Pediatr Res. 2021 Dec 24;91(2):447–453. doi: 10.1038/s41390-021-01879-8

Figure 3: Targeted immunomodulatory therapies in sepsis.

Figure 3:

Schematic depicting therapies trialed to target specific areas of immune dysregulation in sepsis. Treg: regulatory T cell, HLA-DR: human leukocyte antigen-DR, IFN: interferon, TNF: tumor necrosis factor, IL: interleukin, PD: programmed cell death, PDL: programmed cell death ligand.